1. Home
  2. EIKN vs DRTS Comparison

EIKN vs DRTS Comparison

Compare EIKN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$14.48

Market Cap

731.6M

Sector

Health Care

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.07

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIKN
DRTS
Founded
2019
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
731.6M
607.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EIKN
DRTS
Price
$14.48
$7.07
Analyst Decision
Buy
Strong Buy
Analyst Count
6
3
Target Price
$25.60
$8.00
AVG Volume (30 Days)
352.2K
302.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.29
$2.30
52 Week High
$16.50
$8.60

Technical Indicators

Market Signals
Indicator
EIKN
DRTS
Relative Strength Index (RSI) 50.57 47.90
Support Level $13.40 $6.90
Resistance Level $15.97 $7.77
Average True Range (ATR) 1.39 0.47
MACD -0.03 -0.11
Stochastic Oscillator 39.71 33.91

Price Performance

Historical Comparison
EIKN
DRTS

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: